Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Short Bowel Syndrome Clinical Trials
Short Bowel Syndrome clinical trials are recruiting across 31 cities. Here are the cities with the most active studies:
Short Bowel Syndrome Trial Phases
11 research organizations are sponsoring short bowel syndrome trials.
About Short Bowel Syndrome
Short bowel syndrome is a condition where the body cannot absorb enough nutrients because a large portion of the small intestine is missing or damaged. It often results from surgical removal. Treatment includes specialized nutrition, medications, and sometimes intestinal transplantation.
Clinical trials are advancing new treatments for short bowel syndrome. Currently, 12 studies are recruiting a combined 2,145 participants across the United States. Research is being conducted by 11 organizations including Boston Children's Hospital, Takeda, Takeoff41, Inc. and 8 others.
2026 Short Bowel Syndrome Research Landscape
As of July 2026, the short bowel syndrome clinical trial landscape includes 12 actively recruiting studies across 31 cities in the United States. These studies are collectively seeking 2,145 participants, with an average enrollment target of 179 per study.
The research spans multiple phases of development: 5 studies are in NA, 3 studies are in PHASE2, 2 studies are in PHASE3, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some short bowel syndrome treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 11 different organizations, including Boston Children's Hospital, Takeda, Takeoff41, Inc., Protara Therapeutics, SterileCare Inc., and 6 others. The large number of sponsors reflects significant research interest and investment in short bowel syndrome treatment advancement.
Geographically, short bowel syndrome trials are most concentrated in Boston, Massachusetts (6 trials); Durham, North Carolina (4 trials); New York, New York (4 trials); Omaha, Nebraska (3 trials); Cleveland, Ohio (3 trials) and 7 other cities.
Featured Short Bowel Syndrome Studies
Highlighted recruiting studies for short bowel syndrome, selected by enrollment size and research scope.
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using data from multiple multidisciplinary intestinal failure centers across the United States and Canada specializing in the care of these participants.
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
The study is about learning and documenting how well participants and physicians understand how to use GATTEX and about potential risks by using a survey (called Knowledge Assessment Survey). This survey, which is conducted every two years, is part of the Gattex Risk Evaluation and Mitigation Strategy (REMS). REMS is a safety program required by the US health authority (FDA) for certain medicines ...
AI-driven Total Parenteral Nutrition Platform
This study tests whether an artificial intelligence (AI) tool can help doctors order total parenteral nutrition (TPN) for babies in the neonatal intensive care unit (NICU). Premature babies often cannot eat by mouth and need nutrition delivered through an IV. Ordering TPN is complex, time-consuming, and mistakes can happen. This study will test an AI tool that suggests TPN formulas to doctors base...
Frequently Asked Questions About Short Bowel Syndrome Clinical Trials
Are there short bowel syndrome clinical trials near me?
Yes, there are 12 short bowel syndrome clinical trials currently recruiting across 31+ cities in the United States, including Boston, Massachusetts; Durham, North Carolina; New York, New York. Browse the studies above to find one at a location convenient for you.
How do I join a short bowel syndrome clinical trial?
To join a short bowel syndrome clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are short bowel syndrome clinical trials free?
Yes, participation in short bowel syndrome clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of short bowel syndrome treatments are being studied?
Current short bowel syndrome clinical trials are testing a range of approaches across NA (5 studies), PHASE2 (3 studies), PHASE3 (2 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 11 research organizations.
Is it safe to participate in short bowel syndrome clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov